Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Lunit Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

Lunit recognized for achievements in Screening & diagnostics

Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry

Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry

Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations

Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations

Through ECR virtual platform, Lunit to present its virtual booth where visitors can interactively learn more about AI software for chest and breast radiology

Lunit Awarded as Technology Pioneer by World Economic Forum

Lunit Awarded as Technology Pioneer by World Economic Forum

The World Economic Forum announced its selection of 100 of the most promising Technology Pioneers of 2020, who are shaping industries from agriculture to healthcare while also working on sustainability issues and much more.

AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries

AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries

-With users for clinical and trial in countries such as Italy, France, Portugal, Brazil, Indonesia, Panama, South Korea, etc., Lunit seeks to become a worldwide provider of AI solution in COVID-19 management

Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified

Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified

Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020

Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020

"Study reflects the possibility of a powerful biomarker from pathology data being newly applied to clinical practice to provide actionable insights”

Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19

Lunit Releases Its AI Online to Support Healthcare Professionals Manage COVID-19

Currently used in South Korea and Brazil coronavirus centers; publicly accessible at http://lunit.io/covid19

Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board

Renowned Oncologist Dr. Tony Mok Joins Lunit Advisory Board

AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall

AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall

Published in Lancet Digital Health

Year
About Lunit

Perfecting Intelligence, Transforming Medicine.

With AI, we aim to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide.

We develop AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.


Lunit, abbreviated from “learning unit,” is an AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit has been named by CB Insights as one of “AI 100” startups transforming healthcare industry.

Lunit's technology has been recognized at international competitions such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft. Lunit is based in Seoul, South Korea.

Lunit
15th floor, 27 Teheran-ro 2-gil, Gangnam-gu,
Seoul, South Korea